Alanno plant flags

Home News & Media

News & Media

Filter by

Sort:

Alfasigma building

Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease

Open Access for Alfasigma’s scientific publications

Filgotinib Shows Positive Topline Results Across Full Spectrum of Axial Spondyloarthritis in OLINGUITO Phase 3 Study

Alfasigma building

Alfasigma Reports Record Growth in First-Ever Financial Results; €1.87 billion Revenue Setting the Stage for Future Growth

ALFASIGMA AT ECCO CONGRESS 2025

Media support

Need support from the press office?

Contact the team

Media centre